Beneficial Deployments Team Supports AI Health Data for 4.6 Billion People

Anthropic and the Gates Foundation are committing $200 million over four years to expand access to artificial intelligence in areas underserved by commercial markets, with a major focus on global health. The partnership will deliver grant funding, Claude usage credits, and technical support to programs spanning health, life sciences, education, and economic mobility. A significant portion of this investment addresses the critical lack of essential health services affecting 4.6 billion people in low- and middle-income countries. Anthropic’s Beneficial Deployments team will develop assessments to evaluate AI performance in healthcare, moving beyond simple access to actively shaping how the technology is used and measured. This collaborative effort aims to accelerate vaccine and therapy development, and empower governments to make data-driven decisions regarding public health.

AI-Driven Healthcare Intelligence for Low-Income Countries

This investment is not simply about providing access to artificial intelligence; it’s a deliberate strategy to shape how AI is utilized and evaluated within healthcare systems facing unique challenges. Recognizing that market forces alone will not deliver equitable outcomes, the partnership prioritizes beneficial deployments, channeling resources toward programs where they are most needed. The largest component of this collaboration will focus on improving health outcomes where approximately 4.6 billion people currently lack access to essential health services. Anthropic’s Beneficial Deployments team will spearhead the creation of tools to allow researchers, developers, and governments to rigorously assess AI performance on critical healthcare tasks. This goes beyond simply offering Claude access; it’s about establishing standardized methods for measuring efficacy and ensuring responsible implementation. The team will also develop public health datasets to further support these evaluations.

Efforts will extend to accelerating vaccine and therapy development, particularly for neglected diseases like polio, HPV, and eclampsia/preeclampsia, which collectively cause approximately 350,000 deaths annually, with 90 percent occurring in low- and middle-income countries. Scientists are already leveraging Claude to identify patterns in research and screen potential drug candidates; this partnership will broaden that scope. The companies stated that they will explore how AI can make it faster and easier for scientists to screen potential vaccine candidates, including vaccines that protect against diseases like polio, computationally before moving into pre-clinical development. Collaboration for Disease Modeling will enhance the accessibility and predictive power of disease transmission forecasts, improving resource allocation for interventions against malaria and tuberculosis.

Claude Supports Literacy & Numeracy via Global AI Alliance

The partnership will implement programs in the US, sub-Saharan Africa, and India, aiming to create public goods such as model benchmarks, datasets, and knowledge graphs to ensure the effectiveness of AI-powered learning tools. A key component of this effort involves co-developing tools to improve educational outcomes for K-12 students, with the first public releases anticipated later this year. In sub-Saharan Africa and India, the collaboration will focus on creating AI-powered applications designed to support foundational literacy and numeracy programs, operating under the umbrella of the Global AI for Learning Alliance (GAILA). This is not solely about technological deployment; the partnership recognizes the need for robust evaluation frameworks. The partnership also extends to economic mobility, supporting programs to improve agricultural productivity for the nearly two billion people reliant on smallholder farming, with plans to refine Claude’s capabilities using datasets of local crops and benchmarks for agricultural applications. The intention is to openly share these tools as public goods, fostering wider access and innovation, and to publish their decision-making process as the partnership scales and learns.

Agricultural & Workforce Tools Enhance Economic Mobility

This partnership, representing a $200 million commitment over four years, will focus on refining Claude, Anthropic’s AI model, with agriculture-specific improvements, including datasets of local crops and benchmarks to assess performance in agricultural applications. These tools will ultimately be released as public goods, allowing wider access to AI-driven solutions for increased productivity. The initiative acknowledges that simply providing AI access is insufficient; instead, the focus is on creating tools tailored to specific needs and ensuring their effective implementation. Beyond agriculture, the collaboration addresses workforce development in the United States, concentrating on portable records of skills and certifications. This aims to allow individuals to seamlessly transfer credentials between educational institutions and employers, fostering greater career flexibility.

Simultaneously, the partnership will develop trustworthy career guidance tools for both new job market entrants and those undergoing retraining, alongside systems to measure the effectiveness of economic mobility interventions by linking training program data to actual employment outcomes. This data-driven approach seeks to identify which programs demonstrably improve job and wage gains, optimizing resource allocation and maximizing impact. Anthropic stated that they are looking forward to working with their partners to set up these programs and apply Claude to real-world problems, emphasizing a commitment to transparency and sharing learnings as the partnership scales. The company intends to publish its decision-making processes, fostering a broader understanding of how AI can be deployed for societal benefit and measurable impact.